絞り込み

16533

広告

Bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors. Eight cases with clinical and immunological characterization.

著者 García-Díez I , Ivars-Lleó M , López-Aventín D , Ishii N , Hashimoto T , Iranzo P , Pujol RM , España A , Herrero-Gonzalez JE
Int J Dermatol.2018 Apr 23 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (53view , 0users)

Full Text Sources

Dipeptidyl peptidase-4 (DPP-4) inhibitors have increasingly been identified as causative agents of bullous pemphigoid. The clinical and immunological characteristics of this pemphigoid variant are still unclear. The objective of our study was to analyze the clinical and immunological features of patients with pemphigoid induced by DPP-4 inhibitors.
PMID: 29682739 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード